Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06606054 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

WSO BEAT STROKE Initiative

Study acronym: BEAT STROKE
StatusNot Yet Recruiting
PhaseNot applicable
Started2027-03
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 28 months later Oct 2025 → Mar 2028
Primary endpoint reworded 1 of 1 changed
See other at-risk trials from Luciano A. Sposato

Amendment history

2026-09-19
critical
Primary endpoint(s) modified1 entry, revised
WasDifference between the baseline and 6-month mean WSO BEAT Neurocardiology Score
NowDifference between the baseline and 6-month mean WSO BEAT-STROKE Neurocardiology Score
Sponsor changed: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's → Luciano A. Sposato-75 characters
WasLondon Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
NowLuciano A. Sposato
Primary completion pushed: 2025-10 → 2028-03
Completion pushed: 2026-12 → 2029-12
2025-03-27
minor
Study Identification, Study Status, Contacts/Locations v1
Completion date2025-12→2026-12
Start date2024-10→2025-07
Study sitescontacts updated at 1 of 1 site
2024-09-18
minor
Original filing
3,268 trials monitored
See 122 trials at risk
The WSO Brain and hEart globAl iniTiative - STROKE (BEAT-STROKE) is a cluster randomized controlled trial, testing whether an educational and implementation Neurocardiology tool can improve adherence to best practice recommendations for secondary stroke prevention of cardioembolic strokes, as defined by the WSO Systematic Review and Synthesis of Global Stroke Guidelines or more recent high-quality evidence published after the last stroke guidelines1
Trial Details
NCT Number NCT06606054
Lead Sponsor Luciano A. Sposato
Collaborators: W.L.Gore & Associates, Medtronic
Conditions Stroke, PFO - Patent Foramen Ovale, Atrial Fibrillation (AF)
Enrollment 2,400 participants
Start Date 2027-03
Primary Completion 2028-03 (estimated)
Study Completion 2029-12 (estimated)
Updated on ClinicalTrials.gov 2026-09-18